Publications2023-02-15T20:23:19+03:00
Support of publications

Based on its mission, the Hellenic Institute for the Study of Sepsis is supporting three types of publications of manuscripts:
a) manuscripts of the Hellenic Sepsis Study Group;
b) manuscripts on hidradenitis suppurativa; and
c) manuscripts on sepsis.
Support is provided to both pre-clinical and clinical studies and involves the expenses for personnel and consumables.
A list of supported publications is provided below.

The majority of manuscripts published by the Hellenic Sepsis Study Group, are coming from the registry of patients that has started in 2006 and that has been approved by the Ethics Committees of the hospitals (details on Ethical Approval are provided on the Methods section of each manuscript).

The manuscripts are classified by research topic. When the copyright belongs to the authors the entire pdf is given for free or else the manuscript is linked to the PubMed respective site.

Our Library

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Publication in Nature Medicine
From the related study SAVE-MORE to the approval of the study drug by EMA and FDA
More details
12September, 2023

A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis

By |September 12th, 2023|Categories: Publications, Therapeutics|Tags: , , |

Nicky Solomonidi, Panayiotis G. Vlachoyiannopoulos, Maria Pappa, Georgia Liantinioti, Sofia Ktena, Evangelos Theotikos, Antonia Elezoglou, Mihai G. Netea, and Evangelos J. Giamarellos-Bourboulis iScience 2023 Aug 19;26(9):107670 DOI: 10.1016/j.isci.2023.107670Download pdf 🡇 Funding The study was supported in part by the Hellenic Institute for the Study of Sepsis and in part by Janssen.

7September, 2023

Immune responses of patients on maintenance hemodialysis after infection by SARS-CoV-2: a prospective observational cohort study

By |September 7th, 2023|Categories: Publications|Tags: , |

Dimitra Bacharaki, Minas Karagiannis, Panagiotis Giannakopoulos, Evangelos Papachristou, Dimitrios Divanis, Aggeliki Sardeli, Dimitra Petrou, Petros Nikolopoulos, Adamantia Bratsiakou, Vassiliki Zoi, Nikitas Piliouras, Georgia Damoraki, Vassilios Liakopoulos, Dimitrios Goumenos and Evangelos J. Giamarellos-Bourboulis BMC Infectious Diseases (2023) 23:581 DOI: 10.1186/s12879-023-08569-2Download pdf 🡇 Funding The study was funded by the Hellenic Institute for

3August, 2023

Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control

By |August 3rd, 2023|Categories: Publications|Tags: , |

Evangelos J. Giamarellos-Bourboulis on behalf of the European Sepsis Alliance (ESA), Annelies S. Zinkernagel on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Edoardo De Robertis on behalf of the European Society of Anesthesiology and Intensive Care (ESAIC), Élie Azoulay on behalf of the European Society for Intensive Care Medicine

7July, 2023

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes

By |July 7th, 2023|Categories: Biomarkers, Publications|Tags: , |

  Nick Keur, Maria Saridaki, Isis Ricano-Ponce, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis, Vinod Kumar Respiratory Medicine 2023 Jun 25; 217:107331 DOI: 10.1016/j.rmed.2023.107331Download pdf 🡇 Funding   This work was funded by the ZonMw (10430012010002) to VK. The SAVE study was funded by the Hellenic Institute for the Study of Sepsis, Swedish Orphan

9March, 2023

Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID‑19

By |March 9th, 2023|Categories: Biomarkers, Publications|Tags: |

 Evdoxia Kyriazopoulou, Konstantinos Leventogiannis, Georgios Tavoulareas, Efstratios Mainas, Konstantinos Toutouzas, Christos Mathas, Athanassios Prekates, Vissaria Sakka, Periklis Panagopoulos, Konstantinos Syrigos & Evangelos J. Giamarellos-Bourboulis Scientific Reports 13, Article number: 3814 (2023) DOI: 10.1038/s41598-023-30807-5Download pdf 🡇 Funding  The study was funded in part by the FrameWork 7 project HemoSpec (Grant 611682) and in part

10February, 2023

Case report: The devil was hidden in the mastocytes – an unusually fulminant case of indolent systemic mastocytosis in a 45-year-old patient, missed for almost 20 years

By |February 10th, 2023|Categories: Epidemiology, Publications|

Aristeidis E. Boukouris, Ioannis Michelakis, Dionysios Metaxas, Gianna Karapati, George Kanellis, Athina Lioni, Vasiliki Tzavara Frontiers Immunology, 14:1134587 DOI: 10.1111/cea.12318Download pdf 🡇 Funding This study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: Case report

Go to Top